About the Authors

Chad K Heazlewood, Rajaraman Eri, Sharyn B Tauro, Chin Wen Png, Rachel Adams, Timothy H. J Florin, Michael A McGuckin
Mucin and IBD Research Teams, Mucosal Diseases Program, Mater Medical Research Institute, and the University of Queensland, Aubigny Place, Mater Health Services, South Brisbane, Queensland, Australia

Matthew C Cook, Keats A Nelms
Immunology and Inflammation Group, Phenomix Australia, Acton, Australia

Gareth R Price
Molecular Genetics Team, Mater Medical Research Institute, and the University of Queensland, Aubigny Place, Mater Health Services, South Brisbane, Queensland, Australia

Douglas Taupin
Gastroenterology Unit, Canberra Hospital, Woden, Australia

David J Thornton
Wellcome Trust Centre for Cell Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom

Tanya L Crockford, Richard J Cornall
Nuffield Dept of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

Masato Kato
Dendritic Cell Program, Mater Medical Research Institute, Aubigny Place, Mater Health Services, South Brisbane, Queensland, Australia

Nancy A Hong
Phenomix Corporation, San Diego, California, United States of America

Christopher C Goodnow
Division of Immunology and Genetics and Australian Phenomics Facility, John Curtin School of Medical Research, The Australian National University, Canberra, Australia

Corresponding Author

mmcguckin@mmri.mater.org.au

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

CKH, MCC, RE, GRP, SBT, DT, DJT, CWP, TLC, RA, MK, KAN, NAH, and MAM planned and conducted experiments, analysed data, and contributed to preparation of the manuscript. RJC, THJF, and CCG were involved in experimental planning, data analysis and preparation of the manuscript.